Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0001209191-15-057204

Director acquired 11,627,320 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

AFEYAN NOUBAR · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Owned after D/I
2015-06-26 Conversion : show line 1 in the form +8,822,420 8,822,420 I
2015-06-26 Conversion : show line 2 in the form +2,205,603 2,205,603 I
2015-06-26 Conversion : show line 3 in the form +599,297 599,297 I

Table II: Derivative

8 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-06-26 Conversion : show line 4 in the form Series A Convertible Preferred Stock −6,105,362 6,105,362 0 I
2015-06-26 Conversion : show line 5 in the form Series A Convertible Preferred Stock −1,526,338 1,526,338 0 I
2015-06-26 Conversion : show line 6 in the form Series A Convertible Preferred Stock −599,297 599,297 0 I
2015-06-26 Conversion : show line 7 in the form Series A-2 Convertible Preferred Stock −898,877 898,877 0 I
2015-06-26 Conversion : show line 8 in the form Series A-2 Convertible Preferred Stock −224,719 224,719 0 I
2015-06-26 Conversion : show line 9 in the form Series B Convertible Preferred Stock −1,818,181 1,818,181 0 I
2015-06-26 Conversion : show line 10 in the form Series B Convertible Preferred Stock −454,546 454,546 0 I
2015-06-25 Grant or award : show line 11 in the form Stock Option (right to buy) +15,000 $18.00 2025-06-24 15,000 15,000 I
Loading xslF345X03/doc4.xml…